Impact of Human Cytomegalovirus Infection and its Immune Response on Survival of Patients with Ovarian Cancer
暂无分享,去创建一个
O. N. Kostopoulou | J. Carlson | A. Hirschberg | A. Rahbar | C. Söderberg-Nauclér | A. Estekizadeh | B. Davoudi | H. Cui | A. Rådestad
[1] R. McLendon,et al. Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination , 2017, Clinical Cancer Research.
[2] E. Yeh,et al. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy , 2016, npj Breast Cancer.
[3] T. Curry,et al. Ovarian cancer: involvement of the matrix metalloproteinases. , 2015, Reproduction.
[4] M. Coleman,et al. Cancer survival: the CONCORD-2 study – Authors' reply , 2015, The Lancet.
[5] S. Hankinson,et al. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers , 2015, Steroids.
[6] C. Söderberg-Nauclér,et al. Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options. , 2015, World journal of experimental medicine.
[7] Katherine K. Matthews,et al. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. , 2014, Cancer research.
[8] R. Kurman. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] Abdul-Aleem Mohammad,et al. Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target? , 2013, International journal of cancer.
[10] G. Stragliotto,et al. Survival in patients with glioblastoma receiving valganciclovir. , 2013, The New England journal of medicine.
[11] G. Stragliotto,et al. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[12] T. Olsson,et al. Changes to anti-JCV antibody levels in a Swedish national MS cohort , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[13] J. Hartman,et al. High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes , 2013, PloS one.
[14] G. Senthilkumar,et al. Viral and bacterial aetiologies of epithelial ovarian cancer , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[15] Yan-ling Hu,et al. Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and Cathepsin L in diagnosis of ovarian cancer , 2012, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[16] D. Zurakowski,et al. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. , 2011, Gynecologic oncology.
[17] C. Cobbs. Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis , 2011, Herpesviridae.
[18] P. Siesjö,et al. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. , 2011, The Journal of clinical investigation.
[19] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[20] C. Rancourt,et al. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells , 2011, British Journal of Cancer.
[21] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[22] P. Eriksson,et al. Infection with Human Cytomegalovirus Alters the MMP-9/TIMP-1 Balance in Human Macrophages , 2008, Journal of Virology.
[23] D. Coen,et al. Phosphorylation of Retinoblastoma Protein by Viral Protein with Cyclin-Dependent Kinase Function , 2008, Science.
[24] Richard D. Smith,et al. Human Cytomegalovirus UL97 Kinase Activity Is Required for the Hyperphosphorylation of Retinoblastoma Protein and Inhibits the Formation of Nuclear Aggresomes , 2008, Journal of Virology.
[25] J. Sinclair. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[26] C. Cobbs,et al. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. , 2008, Cancer research.
[27] O. Mandelboim,et al. Tumor and viral recognition by natural killer cells receptors. , 2006, Seminars in cancer biology.
[28] Rob Leurs,et al. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis , 2006, Proceedings of the National Academy of Sciences.
[29] Ofer Levi,et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus , 2005, Nature Immunology.
[30] Yoon-Jae Song,et al. Inhibition of Cell Division by the Human Cytomegalovirus IE86 Protein: Role of the p53 Pathway or Cyclin-Dependent Kinase 1/Cyclin B1 , 2005, Journal of Virology.
[31] D. Abate,et al. Major Human Cytomegalovirus Structural Protein pp65 (ppUL83) Prevents Interferon Response Factor 3 Activation in the Interferon Response , 2004, Journal of Virology.
[32] C. Söderberg-Nauclér,et al. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus‐negative blood donors , 2004, Transfusion.
[33] Jindrich Cinatl,et al. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. , 2004, FEMS microbiology reviews.
[34] T. Shenk,et al. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] C. Cobbs,et al. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. , 2003, The Journal of urology.
[36] B. Plachter,et al. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. , 2003, Blood.
[37] Kirby I Bland,et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer , 2002, The Lancet.
[38] Thomas Shenk,et al. Altered Cellular mRNA Levels in Human Cytomegalovirus-Infected Fibroblasts: Viral Block to the Accumulation of Antiviral mRNAs , 2001, Journal of Virology.
[39] M. Jackson,et al. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] E. Kieff,et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] T. Gingeras,et al. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] E. Fortunato,et al. Cell Cycle Dysregulation by Human Cytomegalovirus: Influence of the Cell Cycle Phase at the Time of Infection and Effects on Cyclin Transcription , 1998, Journal of Virology.
[43] S. Larsson,et al. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time , 1998, Transfusion.
[44] T. Shenk,et al. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] K. Fish,et al. Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors , 1997, Cell.
[46] S. Huong,et al. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters , 1995, Journal of virology.
[47] S. Larsson,et al. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection , 1993, Journal of virology.
[48] R. Stenberg,et al. Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products , 1989, Journal of virology.
[49] L. Grillner. Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different tests. , 1987, Journal of virological methods.
[50] R. McLendon,et al. Long-term Survival in Glioblastoma with Cytomegalovirus pp 65-Targeted Vaccination , 2017 .
[51] M. Coleman,et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. , 2014, The Lancet. Oncology.
[52] A. Russo,et al. Hereditary ovarian cancer. , 2009, Critical reviews in oncology/hematology.